Oh-Biologika-2023-17 - Bevacizumab

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 68025763

  Document Type - Tender Notices

Description - The health insurance companies involved are pursuing the goal of concluding discount agreements for the active ingredient bevacizumab with all suitable pharmaceutical companies in accordance with Section 130a (8) SGB V. The contract is concluded as p art of the Open House Biologicals process of the health insurance companies involved: Individual negotiations on the content of the contract are not conducted, uniform conditions apply. The cash registers involved do not guarantee individual contractual partners any exclusivity. The contract period is a maximum of 24 months starting on August 1st, 2023 (different start at hkk: July 1st, 2024). The contract ends on July 31, 2025 at the latest, reg

Gt Ref Id - 68025763

Deadline - Jul 31, 2025